E.B.L. van Dorst

1.9k total citations
24 papers, 1.0k citations indexed

About

E.B.L. van Dorst is a scholar working on Reproductive Medicine, Epidemiology and Oncology. According to data from OpenAlex, E.B.L. van Dorst has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Reproductive Medicine, 8 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in E.B.L. van Dorst's work include Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (5 papers) and BRCA gene mutations in cancer (4 papers). E.B.L. van Dorst is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (5 papers) and BRCA gene mutations in cancer (4 papers). E.B.L. van Dorst collaborates with scholars based in Netherlands, United States and United Kingdom. E.B.L. van Dorst's co-authors include Leon F.A.G. Massuger, Marc van Beurden, Eveline M. A. Bleiker, Marian J.E. Mourits, Neil K. Aaronson, Heiðdís Valdimarsdóttir, Katja N. Gaarenstroom, Joanna B. Madalinska, H. Boonstra and Cecilie E. Kiserud and has published in prestigious journals such as Journal of Clinical Oncology, American Journal Of Pathology and Journal of the American Academy of Dermatology.

In The Last Decade

E.B.L. van Dorst

24 papers receiving 981 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E.B.L. van Dorst Netherlands	12	402	356	282	215	154	24	1.0k
C. C. M. Beerendonk Netherlands	22	876 2.2×	214 0.6×	177 0.6×	954 4.4×	57 0.4×	67	1.6k
Peter Grant Australia	21	517 1.3×	83 0.2×	266 0.9×	176 0.8×	152 1.0×	58	1.2k
Louise Bath United Kingdom	22	680 1.7×	324 0.9×	288 1.0×	787 3.7×	40 0.3×	38	1.7k
Kristen M. Shannon United States	19	78 0.2×	771 2.2×	419 1.5×	131 0.6×	74 0.5×	43	1.5k
Frans J.M. Huikeshoven Netherlands	18	169 0.4×	168 0.5×	99 0.4×	171 0.8×	89 0.6×	51	972
M.J. Heineman Netherlands	20	553 1.4×	181 0.5×	64 0.2×	324 1.5×	42 0.3×	42	1.1k
R Chatterjee United Kingdom	20	476 1.2×	54 0.2×	212 0.8×	629 2.9×	51 0.3×	32	1.2k
Mindy S. Christianson United States	19	550 1.4×	92 0.3×	80 0.3×	542 2.5×	33 0.2×	87	1.1k
Deborah J. Goldfrank United States	13	101 0.3×	146 0.4×	267 0.9×	53 0.2×	30 0.2×	28	520
Thomas F. Rocereto United States	13	522 1.3×	94 0.3×	283 1.0×	72 0.3×	227 1.5×	21	1.2k

Countries citing papers authored by E.B.L. van Dorst

Since Specialization

Citations

This map shows the geographic impact of E.B.L. van Dorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.B.L. van Dorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.B.L. van Dorst more than expected).

Fields of papers citing papers by E.B.L. van Dorst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.B.L. van Dorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.B.L. van Dorst. The network helps show where E.B.L. van Dorst may publish in the future.

Co-authorship network of co-authors of E.B.L. van Dorst

This figure shows the co-authorship network connecting the top 25 collaborators of E.B.L. van Dorst. A scholar is included among the top collaborators of E.B.L. van Dorst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.B.L. van Dorst. E.B.L. van Dorst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Woopen, Hannah, Jalid Sehouli, Alison Davis, et al.. (2022). GCIG-Consensus guideline for Long-term survivorship in gynecologic Cancer: A position paper from the gynecologic cancer Intergroup (GCIG) symptom benefit committee. Cancer Treatment Reviews. 107. 102396–102396. 7 indexed citations

Helsper, Charles W., E.B.L. van Dorst, Thijs van Dalen, et al.. (2022). Effects of structured involvement of the primary care team versus standard care after a cancer diagnosis on patient satisfaction and healthcare use: the GRIP randomised controlled trial. BMC Primary Care. 23(1). 145–145. 1 indexed citations

Frederix, G. W. J., Mary E. Velthuizen, Maaike A. van der Aa, et al.. (2022). Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspective. Gynecologic Oncology. 167(1). 115–122. 8 indexed citations

Vervoort, Sigrid C. J. M., Anne M. May, E.B.L. van Dorst, et al.. (2021). Treatment decision‐making and the added value of the general practitioner: A qualitative exploration of cancer patients' perspectives. European Journal of Cancer Care. 30(3). e13410–e13410. 4 indexed citations

Hulsbergen, Alexander, E.B.L. van Dorst, Vasileios K. Kavouridis, et al.. (2020). Age, pathology and CA-125 are prognostic factors for survival in patients with brain metastases from gynaecological tumours. Clinical and Translational Radiation Oncology. 24. 11–15. 2 indexed citations

Musoro, Jammbe, Corneel Coens, Elfriede Greimel, et al.. (2020). Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancer. Gynecologic Oncology. 159(2). 515–521. 15 indexed citations

Slomovitz, Brian M., Allan Covens, Jacobus van der Velden, et al.. (2020). Radiotherapy as an alternative treatment for inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: Results of GROINSS-V II. Gynecologic Oncology. 159. 3–3. 3 indexed citations

Meeuwis, K.A.P., E.B.L. van Dorst, Johan Bulten, et al.. (2019). P191 Paget trial: topical 5% imiquimod for vulvar paget disease, first results of clinical efficacy. A170.3–A171. 1 indexed citations

Linden, M. van der, Maaike H.M. Oonk, Helena C. van Doorn, et al.. (2018). Vulvar Paget disease: A national retrospective cohort study. Journal of the American Academy of Dermatology. 81(4). 956–962. 39 indexed citations

10.

Linden, M. van der, K.A.P. Meeuwis, E.B.L. van Dorst, et al.. (2017). The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease. JMIR Research Protocols. 6(9). e178–e178. 16 indexed citations

11.

Beurden, Marc van, Jacobien M. Kieffer, Eveline M. A. Bleiker, et al.. (2017). Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study. European Journal of Cancer. 84. 159–167. 33 indexed citations

12.

Schover, Leslie R., et al.. (2014). Sexual dysfunction and infertility as late effects of cancer treatment. European Journal of Cancer Supplements. 12(1). 41–53. 157 indexed citations

13.

Dorst, E.B.L. van, et al.. (2012). Acceptance of Genetic Counseling and Testing in a Hospital‐Based Series of Patients with Gynecological Cancer. Journal of Genetic Counseling. 22(3). 345–357. 6 indexed citations

14.

Heintz, A. Peter M., W P Mali, G.A.P. de Kort, et al.. (2009). Lymph node detection by MRI before and after a systematic pelvic lymphadenectomy. Gynecologic Oncology. 114(2). 315–318. 9 indexed citations

15.

Beerman, H, E.B.L. van Dorst, Vibeke Kuenen‐Boumeester, & Pancras C.W. Hogendoorn. (2009). Superior performance of liquid-based versus conventional cytology in a population-based cervical cancer screening program. Gynecologic Oncology. 112(3). 572–576. 77 indexed citations

16.

Madalinska, Joanna B., Marc van Beurden, Eveline M. A. Bleiker, et al.. (2007). Predictors of Prophylactic Bilateral Salpingo-Oophorectomy Compared With Gynecologic Screening Use in BRCA1/2 Mutation Carriers. Journal of Clinical Oncology. 25(3). 301–307. 60 indexed citations

17.

Madalinska, Joanna B., Eveline M. A. Bleiker, Marc van Beurden, et al.. (2005). Quality-of-Life Effects of Prophylactic Salpingo-Oophorectomy Versus Gynecologic Screening Among Women at Increased Risk of Hereditary Ovarian Cancer. Journal of Clinical Oncology. 23(28). 6890–6898. 183 indexed citations

18.

Oonk, Maaike H.M., Joanne A. de Hullu, Anca C. Ansink, et al.. (2005). 0002: CHANCES FOR ADDITIONAL METASTASES IN VULVAR CANCER PATIENTS WITH A POSITIVE SENTINEL LYMPH NODE (SN). International Journal of Gynecological Cancer. 15. 51–51. 1 indexed citations

19.

Boer, Carla J. de, E.B.L. van Dorst, J. Han van Krieken, et al.. (1999). Changing Roles of Cadherins and Catenins during Progression of Squamous Intraepithelial Lesions in the Uterine Cervix. American Journal Of Pathology. 155(2). 505–515. 77 indexed citations

20.

Hogendoorn, Pancras C.W., E.B.L. van Dorst, Sjoerd H. van der Burg, et al.. (1993). Antigen size influences the type of glomerular pathology in chronic serum sickness. Nephrology Dialysis Transplantation. 8(8). 703–710. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact